U.S. markets closed

Assicurazioni Generali S.p.A. (ARZGY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
11.01+0.17 (+1.57%)
At close: 3:36PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close10.84
Bid0.00 x 0
Ask0.00 x 0
Day's Range10.74 - 11.01
52 Week Range6.55 - 11.25
Avg. Volume2,249
Market Cap34.676B
Beta (5Y Monthly)1.16
PE Ratio (TTM)12.07
Earnings DateN/A
Forward Dividend & Yield0.89 (8.18%)
Ex-Dividend DateOct 18, 2021
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for ARZGY

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: ageas SA/NVAgeas is a life and non-life insurance company that derives most of its income from life and savings, mostly from Belgium, and is headquartered in Brussels. Ageas is essentially the result of the failed bid for ABN Amro by Banco Santander, Fortis, and Royal Bank of Scotland. The capital requirements placed on these banks as a result of the acquisition combined with severe write-downs on its collateralized debt obligations in the case of Fortis left the business requiring capital. Understandably, not very successful capital raising during the financial crisis wasn’t enough and the bank, Fortis, had to be sold and nationalized. What remained was Fortis insurance, which in 2010 was renamed Ageas.
    Fair Value
    Economic Moat
    29 days agoMorningstar
View more
  • Reuters

    Factbox: Billionaires battle CEOs at Italy's Generali and Mediobanca

    Power struggles at insurer Generali and Mediobanca have billionaires Leonardo Del Vecchio and Francesco Gaetano Caltagirone pitted against the CEOs of both groups. Del Vecchio, 86, Caltagirone, 78, clinched a shareholder pact in September to consult over decisions concerning Generali ahead of a general meeting in early 2022 to name a new board. They control a combined 12.5% stake in the insurer, after a third smaller investor recently joined their pact, and are opposing a third mandate for Generali's current CEO Philippe Donnet, who has the backing of Mediobanca.

  • Reuters

    Mediobanca's top investor Del Vecchio seeks more clout

    MILAN (Reuters) -Eyewear billionaire Leonardo Del Vecchio has stepped up pressure on Mediobanca's top managers by proposing governance changes at the Italian merchant bank, two years after emerging as its top shareholder. The move comes as Del Vecchio, 86, is engaged in a boardroom spat with Mediobanca over Generali, Italy's top insurer in which Mediobanca is the biggest shareholder. The founder of Ray-Ban owner Luxottica and one of Italy's richest man, Del Vecchio is also a long-time investor in Generali.

  • Reuters

    Generali CEO wins board backing amid shareholder row

    MILAN (Reuters) -The board of Assicurazioni Generali on Monday threw its weight behind the reappointment of Chief Executive Philippe Donnet, overlooking opposition from two leading shareholders in Italy's top insurer, two people close to the matter said. Donnet's fate had been called into question by a boardroom row at Generali, Europe's third-largest insurer and one of Italy's most prized financial assets, just as the French manager prepared to present a new business plan in December. The two sources said Generali's outgoing board had agreed by a majority vote to file a slate of nominees for shareholders to vote upon in the spring, including Donnet as CEO.